Innovative microfluidic chip uses only standard lab microscope to spot nano-biomolecules without any fluorescent labels
A novel invention by a team of researchers from the National University of Singapore (NUS) holds promise for a faster and cheaper way to diagnose diseases with high accuracy. Professor Zhang Yong from the Department of Biomedical Engineering at the NUS Faculty of Engineering and his team have developed a tiny microfluidic chip that could effectively detect minute amounts of biomolecules without the need for complex lab equipment.
Diseases diagnostics involves detection and quantification of nano-sized bio-particles such as DNA, proteins, viruses, and exosomes (extracellular vesicles). Typically, detection of biomolecules such as proteins are performed using colorimetric assays or fluorescent labelling with a secondary antibody for detection, and requires complex optical detection equipment such as fluorescent microscopy or spectrophotometry.
One alternative to reduce cost and complexity of disease detection is the adoption of label-free techniques, which are gaining traction in recent times. However, this approach requires precision engineering of nano-features (in a detection chip), complex optical setups, novel nano-probes (such as graphene oxide, carbon nanotubes, and gold nanorods) or additional amplification steps such as aggregation of nanoparticles to achieve sensitive detection of biomarkers.
“Our invention is an example of disruptive diagnostics. This tiny biochip can sensitively detect proteins and nano-sized polymer vesicles with a concentration as low as 10ng/mL (150 pM) and 3.75?g/mL respectively. It also has a very small footprint, weighing only 500 mg and is 6mm³ in size. Detection can be performed using standard laboratory microscopes, making this approach highly attractive for use in point-of-care diagnostics,” explained Prof Zhang.
His team, comprising Dr Kerwin Kwek Zeming and two NUS PhD students Mr Thoriq Salafi and Ms Swati Shikha, published their findings in scientific journal Nature Communications on 28 March 2018.
Novel approach for disease diagnosis
This novel fluorescent label-free approach uses the lateral shifts in the position of the microbead substrate in pillar arrays, for quantifying the biomolecules, based on the change in surface forces and size, without the need of any external equipment. Due to the usage of lateral displacement, the nano-biomolecules can be detected in real-time and the detection is significantly faster in comparison to fluorescent label based detection.
“These techniques can also be extended to many other types of nano-biomolecules, including nucleic acid and virus detection. To complement this chip technology, we are also developing a portable smartphone-based accessory and microfluidic pump to make the whole detection platform portable for outside laboratory disease diagnostics. We hope to further develop this technology for commercialisation,” said Prof Zhang.
The Latest on: Disease detection
via Google News
The Latest on: Disease detection
Baylor Lights: #BaylorLights Profile: Dr. Seung Kim
on July 11, 2018 at 12:44 pm
He's hoping the detection of major diseases ranging from cancer to heart disease will one day be as simple as the in-home blood test diabetics use to detect low blood sugar. Kim says through the power ... […]
The Bionic Radiologist: can artificial intelligence enhance human detection of bone disease?
on July 11, 2018 at 8:40 am
Originally published on the NIHR Blog and reproduced here with permission, Professor Andrea Rockall, Clinical Chair of Radiology at Imperial, provides an insight into whether AI can enhance human dete... […]
Going Digital for Heart Disease Detection
on July 10, 2018 at 5:00 pm
As many as six million Americans live with Atrial Fibrillation (AFib). Atrial Fibrillation is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, and heart failure am... […]
Combination of blood test and imaging improves detection of prostate cancer
on July 10, 2018 at 5:12 am
New research from Karolinska Institutet shows that the blood test Stockholm3 together with magnetic resonance imaging and targeted prostate biopsies may lead to a significant decrease in the number of ... […]
Amydis Receives Parkinson’s Disease Grant from Michael J. Fox Foundation
on July 10, 2018 at 4:32 am
SAN DIEGO, July 10, 2018 (GLOBE NEWSWIRE) -- Amydis, Inc., a privately-held pharmaceutical company developing proprietary chemistry and innovative approaches for the detection of amyloid-related disea... […]
SPORTS MEDICINE: When it comes to Lyme disease, early detection is key
on July 9, 2018 at 7:14 pm
In the wake of the IHSAA’s moratorium week, it seems fitting to take a week off, as well, from the typical sports-related worries. With the weather as pleasant as it has been, the athlete in all of us ... […]
Q&A: New AI system that tests for diabetic eye disease
on July 6, 2018 at 12:14 pm
Early detection of DR is very important as treatment can significantly reduce the risk of vision-loss. DJ: How did you develop the AI system that tests for diabetic eye disease? Ryan Amelon: IDx was f... […]
7 recent reports on noninvasive fibrosis detection, staging
on July 5, 2018 at 7:25 am
Other studies have taken the next step after detection to determine the safety of certain gastrointestinal ... of liver fibrosis staging among patients with chronic liver disease, according to a recen... […]
Sonali Bendre's high-grade cancer detection highlights the need for timely diagnosis
on July 5, 2018 at 4:26 am
... prevention are interventions to keep disease from occurring (e.g., immunization for communicable disease); secondary prevention as detection of early asymptomatic disease (e.g., screening); and te... […]
via Bing News